Malaria
Conditions
Interventions
Photodynamic Therapy
Oral Artemisin Combination Therapy
Sponsors
Future Minds Development Initiative
Weber Medical
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients older than 18 years of age, Not on any form of treatment or prophylaxis for malaria, and Who gave an informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients with complicated malaria (haemolytic anaemia, cerebral malaria, algid malaria, nephropathy etc), Those who are on antimalarial treatment or prophylaxis, Pregnant and lactating mothers, Those with concurrent or underlying illnesses, Those with known drug allergy, and Those who did not give informed consent will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of observed and self-reported non-serious adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of serious adverse events over the 28 days observation period ACPR rate until D28 Early treatment failure (ETF) rate Late clinical failure (LCF) rate at D14 and D28 Late parasitological failure (LPF) rate at D14 and D28 Fever clearance time Parasite clearance time Change in haematocrit after 2, 3, 7, 14 and 28 days compared to baseline | — |
Countries
Nigeria
Contacts
Public ContactUbong ;Yetunde Ekpo;Omotosho
Programmes and Research Officer;Grants and Funds Officer
Outcome results
None listed